{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T20:22:11Z","timestamp":1789935731449,"version":"4.0.1"},"reference-count":91,"publisher":"Scientific Scholar","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Hepatitis C virus (HCV) infection is a blood borne and transfusion-transmitted infection (TTI). It has emerged as one of the major health challenges worldwide. In India, around 12-18 million peoples are infected with HCV, but in terms of prevalence percentage, its looks moderate due to large population. The burden of the HCV infection increases due to lack of foolproof screening of blood and blood products before transfusion. The qualified screening and quantification of HCV play an important role in diagnosis and treatment of HCV-related diseases. If identified early, HCV infection can be managed and treated by recently available antiviral therapies with fewer side effects. However, its identification at chronic phase makes its treatment very challenging and sometimes ineffective. The drugs therapy for HCV infection treatment is also dependent on its genotype. Different genotypes of HCV differ from each other at genomic level. The RNA viruses (such as HCV) are evolving perpetually due to interaction and integration among people from different regions and countries which lead to varying therapeutic response in HCV-infected patients in different geographical regions. Therefore, proper diagnosis for infecting virus and then exact determination of genotype become important for targeted treatment. This review summarizes the general information on HCV, and methods used for its diagnosis and genotyping.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_1850_16","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T05:13:15Z","timestamp":1533100395000},"page":"445-455","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":33,"title":["Genotyping &amp; diagnostic methods for hepatitis C virus"],"prefix":"10.25259","volume":"147","author":[{"given":"Anoop","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj Kumar","family":"Rajput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Paliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aakanksha","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reba","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-4-20241212","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"Lavanchy","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"R2-4-20241212","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"R3-4-20241212","first-page":"1","article-title":"Molecular assay and genotyping of hepatitis C virus among infected Egyptian and Saudi Arabian patients","volume":"6","author":"Farag","year":"2015","journal-title":"Virology (Auckl"},{"key":"R4-4-20241212","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1056\/NEJMp1400160","article-title":"Treating hepatitis C in lower-income countries","volume":"370","author":"Jayasekera","year":"2014","journal-title":"N Engl J Med"},{"key":"R5-4-20241212","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"R6-4-20241212","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3851\/IMP2459","article-title":"Transfusion transmission of HCV, a long but successful road map to safety","volume":"17","author":"Selvarajah","year":"2012","journal-title":"Antivir Ther"},{"key":"R7-4-20241212","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy","volume":"282","author":"Neumann","year":"1998","journal-title":"Science"},{"key":"R8-4-20241212","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"R9-4-20241212","first-page":"91","article-title":"Prevalence of anti-HCV antibodies in Western India","volume":"101","author":"Arankalle","year":"1995","journal-title":"Indian J Med Res"},{"key":"R10-4-20241212","first-page":"1","article-title":"World Hepatitis Day-new challenges","volume":"134","author":"Kar","year":"2011","journal-title":"Indian J Med Res"},{"key":"R11-4-20241212","first-page":"146","article-title":"Hepatitis C virus in patients with acute and chronic liver disease","volume":"11","author":"Mehta","year":"1992","journal-title":"Indian J Gastroenterol"},{"key":"R12-4-20241212","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"R14-4-20241212","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/oxfordjournals.epirev.a017995","article-title":"Hepatitis C-related hepatocellular carcinoma: Prevalence around the world, factors interacting, and role of genotypes","volume":"21","author":"Mitra","year":"1999","journal-title":"Epidemiol Rev"},{"key":"R15-4-20241212","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1089-3261(05)70235-X","article-title":"Clinical use of hepatitis C virus tests for diagnosis and monitoring during therapy","volume":"3","author":"Morishima","year":"1999","journal-title":"Clin Liver Dis"},{"key":"R16-4-20241212","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1128\/JCM.40.12.4407-4412.2002","article-title":"Laboratory assays for diagnosis and management of hepatitis C virus infection","volume":"40","author":"Richter","year":"2002","journal-title":"J Clin Microbiol"},{"key":"R17-4-20241212","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1182\/blood.V79.1.169.169","article-title":"IgM antibody response in acute hepatitis C viral infection","volume":"79","author":"Clemens","year":"1992","journal-title":"Blood"},{"key":"R19-4-20241212","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0399-8320(06)73375-9","article-title":"New therapeutic strategies in chronic hepatitis C","volume":"30","author":"Pawlotsky","year":"2006","journal-title":"Gastroenterol Clin Biol"},{"key":"R20-4-20241212","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4254\/wjh.v7.i6.831","article-title":"Hepatitis C virus genetic variability and evolution","volume":"7","author":"Echeverr\u00eda","year":"2015","journal-title":"World J Hepatol"},{"key":"R21-4-20241212","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1128\/jvi.67.3.1385-1395.1993","article-title":"Expression and identification of hepatitis C virus polyprotein cleavage products","volume":"67","author":"Grakoui","year":"1993","journal-title":"J Virol"},{"key":"R23-4-20241212","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes","volume":"197","author":"Bartosch","year":"2003","journal-title":"J Exp Med"},{"key":"R24-4-20241212","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1099\/vir.0.79967-0","article-title":"Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver","volume":"85","author":"Nielsen","year":"2004","journal-title":"J Gen Virol"},{"key":"R25-4-20241212","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/(SICI)1099-1654(200003\/04)10:2<101::AID-RMV268>3.0.CO;2-W","article-title":"The role of the hepatitis C virus glycoproteins in infection","volume":"10","author":"Flint","year":"2000","journal-title":"Rev Med Virol"},{"key":"R26-4-20241212","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1073\/pnas.93.5.1759","article-title":"A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells","volume":"93","author":"Rosa","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-4-20241212","doi-asserted-by":"crossref","first-page":"33228","DOI":"10.1074\/jbc.M202304200","article-title":"Membrane topology of the hepatitis C virus NS2 protein","volume":"277","author":"Yamaga","year":"2002","journal-title":"J Biol Chem"},{"key":"R28-4-20241212","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/jvi.67.5.2832-2843.1993","article-title":"Characterization of the hepatitis C virus-encoded serine proteinase: Determination of proteinase-dependent polyprotein cleavage sites","volume":"67","author":"Grakoui","year":"1993","journal-title":"J Virol"},{"key":"R29-4-20241212","doi-asserted-by":"crossref","first-page":"10773","DOI":"10.1073\/pnas.90.22.10773","article-title":"Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus","volume":"90","author":"Hijikata","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R30-4-20241212","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1128\/jvi.69.12.7519-7528.1995","article-title":"Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation","volume":"69","author":"Bartenschlager","year":"1995","journal-title":"J Virol"},{"key":"R31-4-20241212","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1128\/JVI.78.20.11393-11400.2004","article-title":"An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication","volume":"78","author":"Elazar","year":"2004","journal-title":"J Virol"},{"key":"R32-4-20241212","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1099\/vir.0.80768-0","article-title":"Mobility of the hepatitis C virus NS4B protein on the endoplasmic reticulum membrane and membrane-associated foci","volume":"86","author":"Gretton","year":"2005","journal-title":"J Gen Virol"},{"key":"R33-4-20241212","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0168-1702(02)00146-6","article-title":"Inhibition of protein synthesis by the nonstructural proteins NS4A and NS4B of hepatitis C virus","volume":"90","author":"Florese","year":"2002","journal-title":"Virus Res"},{"key":"R34-4-20241212","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jmv.2129","article-title":"Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo","volume":"66","author":"Kato","year":"2002","journal-title":"J Med Virol"},{"key":"R35-4-20241212","doi-asserted-by":"crossref","first-page":"45670","DOI":"10.1074\/jbc.M204124200","article-title":"Modulation of the hepatitis C virus RNA-dependent RNA polymerase activity by the non-structural (NS) 3 helicase and the NS4B membrane protein","volume":"277","author":"Piccininni","year":"2002","journal-title":"J Biol Chem"},{"key":"R36-4-20241212","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0163-7258(97)00165-4","article-title":"Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase","volume":"78","author":"Gale","year":"1998","journal-title":"Pharmacol Ther"},{"key":"R37-4-20241212","doi-asserted-by":"crossref","first-page":"13088","DOI":"10.1128\/JVI.76.24.13088-13093.2002","article-title":"The hepatitis C virus RNA-dependent RNA polymerase membrane insertion sequence is a transmembrane segment","volume":"76","author":"Ivashkina","year":"2002","journal-title":"J Virol"},{"key":"R38-4-20241212","doi-asserted-by":"crossref","first-page":"44052","DOI":"10.1074\/jbc.M103358200","article-title":"Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase","volume":"276","author":"Schmidt-Mende","year":"2001","journal-title":"J Biol Chem"},{"key":"R39-4-20241212","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/13305","article-title":"Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site","volume":"6","author":"Lesburg","year":"1999","journal-title":"Nat Struct Biol"},{"key":"R40-4-20241212","doi-asserted-by":"crossref","first-page":"11646","DOI":"10.1073\/pnas.1834545100","article-title":"The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences","volume":"100","author":"Sakai","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R41-4-20241212","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-156-4-201202210-00014","article-title":"Hepatitis C: The end of the beginning and possibly the beginning of the end","volume":"156","author":"Alter","year":"2012","journal-title":"Ann Intern Med"},{"key":"R42-4-20241212","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1046\/j.1537-2995.2002.00174.x","article-title":"Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population","volume":"42","author":"Dodd","year":"2002","journal-title":"Transfusion"},{"key":"R43-4-20241212","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1046\/j.1537-2995.2002.00129.x","article-title":"Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe","volume":"42","author":"Roth","year":"2002","journal-title":"Transfusion"},{"key":"R44-4-20241212","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7150\/ijms.3.47","article-title":"The natural history of hepatitis C virus (HCV) infection","volume":"3","author":"Chen","year":"2006","journal-title":"Int J Med Sci"},{"key":"R45-4-20241212","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1349-7006.1990.tb02517.x","article-title":"Transition of antibody to hepatitis C virus from chronic hepatitis to hepatocellular carcinoma","volume":"81","author":"Kiyosawa","year":"1990","journal-title":"Jpn J Cancer Res"},{"key":"R46-4-20241212","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"key":"R47-4-20241212","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4172\/2167-0889.1000187","article-title":"Management of hepatitis C in Indian context: An update","volume":"4","author":"Bhattacharya","year":"2015","journal-title":"J Liver"},{"key":"R48-4-20241212","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0255-0857.118875","article-title":"Genotypes of hepatitis C virus in the Indian sub-continent: A decade-long experience from a tertiary care hospital in South India","volume":"31","author":"Christdas","year":"2013","journal-title":"Indian J Med Microbiol"},{"key":"R49-4-20241212","doi-asserted-by":"crossref","first-page":"e0126764","DOI":"10.1371\/journal.pone.0126764","article-title":"Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia","volume":"10","author":"Wasitthankasem","year":"2015","journal-title":"PLoS One"},{"key":"R50-4-20241212","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4254\/wjh.v8.i3.139","article-title":"Advances in hepatitis C therapy: What is the current state - What come's next?","volume":"8","author":"Zopf","year":"2016","journal-title":"World J Hepatol"},{"key":"R51-4-20241212","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04082","article-title":"Mechanism of action of interferon and ribavirin in treatment of hepatitis C","volume":"436","author":"Feld","year":"2005","journal-title":"Nature"},{"key":"R52-4-20241212","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3350\/kjhep.2012.18.1.22","article-title":"Recent trends in the treatment of chronic hepatitis C","volume":"18","author":"Jun","year":"2012","journal-title":"Korean J Hepatol"},{"key":"R53-4-20241212","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0808010","article-title":"Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection","volume":"361","author":"McHutchison","year":"2009","journal-title":"N Engl J Med"},{"key":"R54-4-20241212","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1515\/jtim-2017-0007","article-title":"Direct acting anti-hepatitis C virus drugs: clinical pharmacology and future direction","volume":"5","author":"Geddawy","year":"2017","journal-title":"J Transl Int Med"},{"key":"R56-4-20241212","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","article-title":"Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens","volume":"151","author":"Pawlotsky","year":"2016","journal-title":"Gastroenterology"},{"key":"R58-4-20241212","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/hep.24641","article-title":"An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Ghany","year":"2011","journal-title":"Hepatology"},{"key":"R59-4-20241212","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jama.2015.1373","article-title":"Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection","volume":"313","author":"Osinusi","year":"2015","journal-title":"JAMA"},{"key":"R60-4-20241212","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1053\/j.gastro.2015.10.013","article-title":"Effectiveness of simeprevir plus sofosbuvir, with or without ribavirin, in real-world patients with HCV genotype 1 infection","volume":"150","author":"Sulkowski","year":"2016","journal-title":"Gastroenterology"},{"key":"R61-4-20241212","first-page":"1312","article-title":"The \u201cgold-standard,\u201d accuracy, and the current concepts: Hepatitis C virus genotype and viremia","volume":"24","author":"Ohno","year":"1996","journal-title":"Hepatology"},{"key":"R62-4-20241212","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: An update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"R64-4-20241212","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1373\/clinchem.2004.041673","article-title":"Genotyping of hepatitis C virus by melting curve analysis: Analytical characteristics and performance","volume":"50","author":"Haverstick","year":"2004","journal-title":"Clin Chem"},{"key":"R65-4-20241212","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/JCM.40.6.2046-2050.2002","article-title":"Genotyping of hepatitis C virus types 1, 2, 3, and 4 by a one-step LightCycler method using three different pairs of hybridization probes","volume":"40","author":"Schr\u00f6ter","year":"2002","journal-title":"J Clin Microbiol"},{"key":"R66-4-20241212","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1128\/JCM.43.6.2810-2815.2005","article-title":"Matrix-assisted laser desorption ionization-time of flight (mass spectrometry) for hepatitis C virus genotyping","volume":"43","author":"Ilina","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R67-4-20241212","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jviromet.2015.05.013","article-title":"Rapid detection of HCV genotyping 1a, 1b, 2a, 3a, 3b and 6a in a single reaction using two-melting temperature codes by a real-time PCR-based assay","volume":"222","author":"Athar","year":"2015","journal-title":"J Virol Methods"},{"key":"R68-4-20241212","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1099\/0022-1317-73-3-673","article-title":"Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources","volume":"73","author":"Okamoto","year":"1992","journal-title":"J Gen Virol"},{"key":"R69-4-20241212","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0168-8278(94)80139-8","article-title":"Hepatitis C virus genotypes in France: Comparison of clinical features of patients infected with HCV type I and type II","volume":"21","author":"Qu","year":"1994","journal-title":"J Hepatol"},{"key":"R70-4-20241212","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1099\/00222615-47-7-643","article-title":"Distribution of genotypes in the 5\u2019 untranslated region of hepatitis C virus in Korea","volume":"47","author":"Park","year":"1998","journal-title":"J Med Microbiol"},{"key":"R71-4-20241212","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1128\/jcm.34.9.2259-2266.1996","article-title":"Second-generation line probe assay for hepatitis C virus genotyping","volume":"34","author":"Stuyver","year":"1996","journal-title":"J Clin Microbiol"},{"key":"R72-4-20241212","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1128\/JCM.42.10.4545-4551.2004","article-title":"Genotyping hepatitis C virus by heteroduplex mobility analysis using temperature gradient capillary electrophoresis","volume":"42","author":"Margraf","year":"2004","journal-title":"J Clin Microbiol"},{"key":"R73-4-20241212","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1128\/JCM.38.2.477-482.2000","article-title":"Simplified hepatitis C virus genotyping by heteroduplex mobility analysis","volume":"38","author":"White","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R75-4-20241212","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J Viral Hepat"},{"key":"R76-4-20241212","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/(SICI)1096-9071(199606)49:2<132::AID-JMV10>3.0.CO;2-G","article-title":"Relevance of RIBA-3 supplementary test to HCV PCR positivity and genotypes for HCV confirmation of blood donors","volume":"49","author":"Dow","year":"1996","journal-title":"J Med Virol"},{"key":"R77-4-20241212","first-page":"15","article-title":"Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA","volume":"68","author":"Barrera","year":"1995","journal-title":"Vox Sang"},{"key":"R78-4-20241212","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1537-2995.1995.351196110893.x","article-title":"Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study","volume":"35","author":"Busch","year":"1995","journal-title":"Transfusion"},{"key":"R79-4-20241212","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.3748\/wjg.v20.i11.2948","article-title":"Current testing strategies for hepatitis C virus infection in blood donors and the way forward","volume":"20","author":"Marwaha","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R80-4-20241212","doi-asserted-by":"crossref","first-page":"596","DOI":"10.7326\/0003-4819-115-8-596","article-title":"Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers","volume":"115","author":"Barrera","year":"1991","journal-title":"Ann Intern Med"},{"key":"R81-4-20241212","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2893.2001.00280.x","article-title":"Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: An analysis of the literature","volume":"8","author":"Colin","year":"2001","journal-title":"J Viral Hepat"},{"key":"R82-4-20241212","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0016-5085(03)00668-1","article-title":"Acute hepatitis C: High rate of both spontaneous and treatment-induced viral clearance","volume":"125","author":"Gerlach","year":"2003","journal-title":"Gastroenterology"},{"key":"R83-4-20241212","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/infdis\/jir422","article-title":"Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus","volume":"204","author":"Smith","year":"2011","journal-title":"J Infect Dis"},{"key":"R84-4-20241212","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM199208063270601","article-title":"The declining risk of post-transfusion hepatitis C virus infection","volume":"327","author":"Donahue","year":"1992","journal-title":"N Engl J Med"},{"key":"R85-4-20241212","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.transci.2013.07.003","article-title":"Evaluation of serological transfusion-transmitted viral diseases and mutliplex nucleic acid testing in Malaysian blood donors","volume":"49","author":"Yaseen","year":"2013","journal-title":"Transfus Apher Sci"},{"key":"R86-4-20241212","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1423-0410.2011.01506.x","article-title":"International survey on NAT testing of blood donations: Expanding implementation and yield from 1999 to 2009","volume":"102","author":"Roth","year":"2012","journal-title":"Vox Sang"},{"key":"R87-4-20241212","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1537-2995.2009.02176.x","article-title":"One-year experience of nucleic acid technology testing for human immunodeficiency virus type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations","volume":"49","author":"Phikulsod","year":"2009","journal-title":"Transfusion"},{"key":"R88-4-20241212","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.transci.2013.03.004","article-title":"Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India","volume":"49","author":"Agarwal","year":"2013","journal-title":"Transfus Apher Sci"},{"key":"R89-4-20241212","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/0973-6247.154250","article-title":"Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety","volume":"9","author":"Kumar","year":"2015","journal-title":"Asian J Transfus Sci"},{"key":"R90-4-20241212","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3126\/jpn.v6i11.15649","article-title":"Significance of nucleic acid testing in window period donations: Revisiting transfusion safety in high prevalence-low resource settings","volume":"6","author":"Mangwana","year":"2016","journal-title":"J Pathol Nepal"},{"key":"R91-4-20241212","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1590\/S0036-46652007000300008","article-title":"Primary screening of blood donors by nat testing for HCV-RNA: Development of an \u201cin-house\u201d method and results","volume":"49","author":"Wendel","year":"2007","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"R92-4-20241212","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1537-2995.2008.01718.x","article-title":"Experience of German Red Cross blood donor services with nucleic acid testing: Results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus","volume":"48","author":"Hourfar","year":"2008","journal-title":"Transfusion"},{"key":"R93-4-20241212","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/0973-6247.95056","article-title":"A study on optimization of plasma pool size for viral infectious markers in Indian blood donors using nucleic acid amplification testing","volume":"6","author":"Mathur","year":"2012","journal-title":"Asian J Transfus Sci"},{"key":"R94-4-20241212","first-page":"26","article-title":"Hepatitis C virus variants and the role of genotyping","volume":"23","author":"Smith","year":"1995","journal-title":"J Hepatol"},{"key":"R95-4-20241212","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jama.297.7.724","article-title":"Molecular diagnostics of hepatitis C virus infection: A systematic review","volume":"297","author":"Scott","year":"2007","journal-title":"JAMA"},{"key":"R97-4-20241212","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0973-6247.126679","article-title":"Nucleic acid testing-benefits and constraints","volume":"8","author":"Hans","year":"2014","journal-title":"Asian J Transfus Sci"},{"key":"R98-4-20241212","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/0973-6247.126688","article-title":"Half a decade of mini-pool nucleic acid testing: Cost-effective way for improving blood safety in India","volume":"8","author":"Chandrashekar","year":"2014","journal-title":"Asian J Transfus Sci"},{"key":"R99-4-20241212","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1537-2995.2010.02804.x","article-title":"Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms","volume":"51","author":"Weusten","year":"2011","journal-title":"Transfusion"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201847050-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T19:00:17Z","timestamp":1751482817000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/genotyping-diagnostic-methods-for-hepatitis-c-virus-a-need-of-low-resource-countries\/"}},"subtitle":["A need of low-resource countries"],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":91,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_1850_16","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}